Georgia Heart Specialists
Covington, Georgia, United States
Heart hospital in Covington, Georgia
4140 Tate St NE B, Covington, GA 30014
About Georgia Heart Specialists
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bristol-Myers Squibb
3
Otsuka Pharmaceutical Development & Commercialization, Inc.
2
Pfizer
2
ARYx Therapeutics
1
Cardiovascular Clinical Studies
1
Cogentus Pharmaceuticals
1
Eli Lilly and Company
1
Clinical Trials at Georgia Heart Specialists
During the past decade, Georgia Heart Specialists conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 6 clinical trials were completed, i.e. on
average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
2002-07-01
2004-07-01
Completed
170
EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan
2003-09-01
2006-07-01
Completed
3,600
Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg
2005-10-01
2006-07-01
Completed
400
Safety Study of Apixaban in Recent Acute Coronary Syndrome
2006-05-01
2008-05-01
Completed
1,741
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
2007-12-01
2009-11-01
Terminated
5,000
Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
2008-05-01
2009-06-01
Unknown status
600
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Georgia Heart Specialists" #1 sponsor was "Bristol-Myers Squibb" with 3 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "ARYx Therapeutics" with 1 trials sponsored and "Cardiovascular Clinical Studies"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Georgia Heart Specialists"
#1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Georgia Heart Specialists
According to Clinical.Site data, the most researched conditions in "Georgia Heart Specialists" are
"Acute Coronary Syndrome" (2 trials), "Cardiovascular Disease" (2 trials), "Congestive Heart Failure" (2 trials), "Myocardial Infarction" (2 trials) and "Acute Coronary Syndrome (ACS)" (1 trials). Many other conditions were trialed in "Georgia Heart Specialists" in a lesser frequency.
Clinical Trials Intervention Types at Georgia Heart Specialists
Most popular intervention types in "Georgia Heart Specialists" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Apixaban" (3 trials), "Tolvaptan" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "ATI-5923" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Georgia Heart Specialists
The vast majority of trials in "Georgia Heart Specialists" are
11 trials for "All" genders.
Clinical Trials Status at Georgia Heart Specialists
Currently, there are NaN active trials in "Georgia Heart Specialists".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Georgia Heart Specialists,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Georgia Heart Specialists, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".